These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 18562760

  • 21. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 22. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

  • 23. Functional volumetric MRI in assessing treatment response to intra-arterial therapy of primary and secondary liver tumors.
    Corona-Villalobos CP, Kamel IR.
    J Comput Assist Tomogr; 2014 Nov; 38(4):513-7. PubMed ID: 24681851
    [Abstract] [Full Text] [Related]

  • 24. Hepatic arterial chemoembolization for management of metastatic melanoma.
    Sharma KV, Gould JE, Harbour JW, Linette GP, Pilgram TK, Dayani PN, Brown DB.
    AJR Am J Roentgenol; 2008 Jan; 190(1):99-104. PubMed ID: 18094299
    [Abstract] [Full Text] [Related]

  • 25. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M.
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of short-term response of high intensity focused ultrasound ablation for primary hepatic carcinoma: utility of contrast-enhanced MRI and diffusion-weighted imaging.
    Zhang Y, Zhao J, Guo D, Zhong W, Ran L.
    Eur J Radiol; 2011 Sep; 79(3):347-52. PubMed ID: 20638211
    [Abstract] [Full Text] [Related]

  • 27. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD, Kizziah MK, Rissing MS.
    J Comput Assist Tomogr; 2011 Jul; 35(6):711-5. PubMed ID: 22082541
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE, Kim SH, Lee SJ, Rhim H.
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [Abstract] [Full Text] [Related]

  • 33. Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma.
    Saito K, Araki Y, Park J, Metoki R, Katsuyama H, Nishio R, Kakizaki D, Moriyasu F, Tokuuye K.
    J Magn Reson Imaging; 2010 Jul; 32(1):229-34. PubMed ID: 20578029
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK, Kim CS, Han YM, Lee YH.
    Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
    [Abstract] [Full Text] [Related]

  • 36. Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging.
    Liu X, Zhou L, Peng W, Qian M.
    Acta Radiol; 2011 Jun 01; 52(5):575-80. PubMed ID: 21498291
    [Abstract] [Full Text] [Related]

  • 37. Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI.
    Gaba RC, Jin B, Wang D, Lewandowski RJ, Ragin AB, Larson AC, Salem R, Omary RA.
    AJR Am J Roentgenol; 2012 May 01; 198(5):1196-202. PubMed ID: 22528913
    [Abstract] [Full Text] [Related]

  • 38. Diffusion-weighted MR: therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit liver.
    Youn BJ, Chung JW, Son KR, Kim HC, Jae HJ, Lee JM, Song IC, Kim IO, Park JH.
    Acad Radiol; 2008 May 01; 15(5):593-600. PubMed ID: 18423316
    [Abstract] [Full Text] [Related]

  • 39. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization.
    Dong S, Ye XD, Yuan Z, Xu LC, Xiao XS.
    Eur J Radiol; 2012 Mar 01; 81(3):472-7. PubMed ID: 21296517
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.